Oliver Dolan, Senior Vice President, Finance at Korro Bio, Inc. (KRRO), sold 5 shares at $13.72 ($69) on 2026-09-11, disclosed to the SEC on 2026-09-14.
Scheduled sale ($69) by Senior Vice President, Finance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |